Oppenheimer Asset Management Inc. Neogenomics Inc Transaction History

Oppenheimer Asset Management Inc.

$8.4 Billion
Q2 2025

A detailed history of Oppenheimer Asset Management Inc. transactions in Neogenomics Inc stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 18,276 shares of NEO stock, worth $177,094. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,276

Previous 31,199 41.42%

Holding current value

$177,094

Previous $296,000 55.07%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 31, 2025	SELL	$6.4 - $10.27 $82,707 - $132,719	-12,923 Reduced 41.42%	18,276 $133,000
Q1 2025 Apr 22, 2025	BUY	$9.09 - $18.61 $8,426 - $17,251	927 Added 3.06%	31,199 $296,000
Q4 2024 Feb 04, 2025	SELL	$13.0 - $18.43 $30,550 - $43,310	-2,350 Reduced 7.2%	30,272 $498,000
Q3 2024 Nov 05, 2024	BUY	$13.4 - $17.73 $1,567 - $2,074	117 Added 0.36%	32,622 $481,000
Q2 2024 Aug 08, 2024	BUY	$13.01 - $15.77 $13,400 - $16,243	1,030 Added 3.27%	32,505 $450,000
Q1 2024 May 06, 2024	BUY	$14.06 - $16.79 $54,819 - $65,464	3,899 Added 14.14%	31,475 $494,000
Q4 2023 Feb 13, 2024	BUY	$11.67 - $20.73 $93,336 - $165,798	7,998 Added 40.85%	27,576 $446,000
Q3 2023 Nov 07, 2023	BUY	$12.15 - $17.85 $73,653 - $108,206	6,062 Added 44.85%	19,578 $240,000
Q2 2023 Aug 02, 2023	BUY	$14.1 - $19.83 $190,575 - $268,022	13,516 New	13,516 $217,000
Q1 2022 May 12, 2022	SELL	$12.15 - $35.28 $88,233 - $256,203	-7,262 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$30.49 - $48.49 $792 - $1,260	26 Added 0.36%	7,262 $248,000
Q3 2021 Nov 12, 2021	SELL	$41.66 - $52.52 $594,571 - $749,565	-14,272 Reduced 66.36%	7,236 $349,000
Q2 2021 Aug 03, 2021	SELL	$36.62 - $51.69 $144,099 - $203,400	-3,935 Reduced 15.47%	21,508 $972,000
Q1 2021 May 17, 2021	BUY	$41.56 - $59.88 $11,927 - $17,185	287 Added 1.14%	25,443 $1.23 Million
Q4 2020 Feb 11, 2021	BUY	$36.08 - $56.47 $28,827 - $45,119	799 Added 3.28%	25,156 $1.36 Million
Q3 2020 Nov 13, 2020	BUY	$33.26 - $40.48 $180,302 - $219,442	5,421 Added 28.63%	24,357 $898,000
Q2 2020 Aug 11, 2020	BUY	$24.21 - $31.02 $280,884 - $359,894	11,602 Added 158.19%	18,936 $586,000
Q1 2020 May 08, 2020	BUY	$20.5 - $34.53 $131,159 - $220,922	6,398 Added 683.55%	7,334 $202,000
Q4 2019 Feb 07, 2020	BUY	$18.96 - $29.84 $14,807 - $23,305	781 Added 503.87%	936 $28,000
Q1 2019 Apr 24, 2019	SELL	$12.14 - $20.46 $20,686 - $34,863	-1,704 Reduced 91.66%	155 $3,000
Q4 2018 Jan 30, 2019	BUY	$11.24 - $18.5 $20,895 - $34,391	1,859 New	1,859 $23,000
Q4 2017 Feb 07, 2018	SELL	$8.02 - $11.18 $47,927 - $66,811	-5,976 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$9.11 - $11.26 $54,441 - $67,289	5,976	5,976 $67,000

Others Institutions Holding NEO

# of Institutions

308

Shares Held

127M

Call Options Held

1.17M

Put Options Held

297K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.22B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.

Account

Oppenheimer Asset Management Inc. Neogenomics Inc Transaction History